Clindamycin Phosphate NDC 71335-2861

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2861Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2861Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71335-2861-1	71335286101	1 BOTTLE, WITH APPLICATOR in 1 CARTON (71335-2861-1) / 30 mL in 1 BOTTLE, WITH APPLICATORMarketed from Oct 24, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clindamycin Phosphate
Generic name (nonproprietary): clindamycin phosphate
Active ingredients: Clindamycin phosphate — 10 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 064050
Marketing start: Sep 17, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 71335-2861_fa467248-6c5e-4efa-9bac-573623586118SPL ID fa467248-6c5e-4efa-9bac-573623586118SPL set ID 576fbdf8-b44d-49bf-a569-601861cc402dRxCUI 309333UNII EH6D7113I8
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335286101 followed by a unit qualifier and the quantity

Package 71335-2861-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 12, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin Phosphate Topical Solution USP, 1% is indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see CONTRAINDICATIONS , WARNINGS and ADVERSE REACTIONS ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 064050

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 064050
Product	Strength	Form · route	Labeler	Product NDC
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	Padagis Israel Pharmaceuticals Ltd	45802-562
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	Bryant Ranch Prepack	71335-2863
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	Bryant Ranch Prepack	72162-1418
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	Bryant Ranch Prepack	63629-8634
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	Bryant Ranch Prepack	63629-8633
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	A-S Medication Solutions	50090-2611